They are the Wnt signaling pathway, prostate cancer, adherent’s junction, insulin signaling pathway, type 2 diabetes mellitus, endometrial cancer, pathways in cancer, and thyroid cancer (Table S2). This evidence concerns the gene INS and thyroid gland carcinoma.